Casodex (bicalutamide) Ongoing Clinical Trial Summary

Casodex™ (bicalutamide) Ongoing studies

A number of clinical trials with Casodex™ (bicalutamide) Ongoing studies are currently in progress.

More studies will be added in due course. Additonal Casodex™ (bicalutamide) Ongoing study information is available on ClinicalTrials.gov.

Study Number	Study Phase	Start Date	Recruitment Status
7054IT/0003	Phase III	24 Dec 2003	Active, not recruiting
7054TR/01	Phase IV	05 Jun 2003	Completed
A comparative trial of the efficacy of two different Nolvadex (NDX) dosing and scheduling regimens in preventing gynecomastia induced by Casodex (CDX) 150 monotherapy in prostate cancer patients.
D6874C00008	Non-interventional study	1 Dec 2007	Recruiting
A pharmacoepidemiological study on the association between bicalutamide treated prostate cancer and risk of coronary heart disease (CHD) and heart failure (HF) in the General Practice Research Database (GPRD)
D6876L00010	Phase IV	1 Aug 1995	Suspended
Longitudinal, randomized, open and prospective clinical trial to evaluate the efficacy of continuous vs intermittent maximum androgen blockade (CMAB vs IMAB) with gosereline-bicalutamide combination in the treatment of hormonal naïve with metastatic prostate cancer.
D6876C00023	Phase III	15 Aug 2004	Active, not recruiting
A Randomized Double-Blind Comparative Trial of Bicalutamide (Casodex™) Versus Placebo in patients with Early Prostate Cancer.
D6876C00024	Phase III	21 Sep 1995	Active, not recruiting
A Randomized, Double-Blind, Parallel-Group Trial Comparing casodex 150mg Once Daily with Placebo in Patients with Non-metastatic Prostate Cancer.
D6876C00025	Phase III	4 Oct 1995	Active, not recruiting
A Randomized, Double-Blind, Parallel-Group Trial Comparing Casodex 150mg Once Daily with Placebo in Patients with Non-metastatic Prostate Cancer.
D6873C00047	Phase II	22 Nov 2004	Active, not recruiting
An Open-label, Non-comparative, Multi-centre Study to Assess the Efficacy and Safety of Bicalutamide When Used in Combination with Anastrozole for the Treatment of Gonadotropin-independent Precocious Puberty in Boys with Testotoxicosis.
NIS-OIT-CAS-2007/2	Non-interventional study	1 Sept 2007	Recruiting
Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer (SORSE)
NIS-OIT-CAS-2007/1	Non-interventional study	1 Sep 2007	Recruiting
Observational retrospective trial on sequential hormonal therapy in patients with prostate cancer
NIS-OKR-CAS-2007/2	Non-interventional study	1 May 2007	Active, not recruiting
An observational study to assess correlation between Prostate Specific Antigen & Beck Anxiety Index in prostate cancer patients under hormonal therapy.